Short Communication: Efficacy of Parenteral Ceftiofur for Treatment of Systemically Mild Clinical Mastitis in Dairy Cattle

The objective of this study was to evaluate the effect of intramuscular (i.m.) ceftiofur (2.2mg/kg) on important outcomes of systemically mild clinical mastitis episodes in lactating dairy cattle. Cows with clinical mastitis were randomly assigned to a treatment group: pirlimycin intramammary (i.m.m...

Full description

Saved in:
Bibliographic Details
Published inJournal of dairy science Vol. 88; no. 10; pp. 3496 - 3499
Main Authors Wenz, J. R, Garry, F. B, Lombard, J. E, Elia, R, Prentice, D, Dinsmore, R. P
Format Journal Article
LanguageEnglish
Published Savoy, IL Elsevier Inc 01.10.2005
Am Dairy Sci Assoc
American Dairy Science Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The objective of this study was to evaluate the effect of intramuscular (i.m.) ceftiofur (2.2mg/kg) on important outcomes of systemically mild clinical mastitis episodes in lactating dairy cattle. Cows with clinical mastitis were randomly assigned to a treatment group: pirlimycin intramammary (i.m.m.) (n=35), pirlimycin i.m.m. and ceftiofur i.m.m. (n=36), cephapirin i.m.m. (n=40), cephapirin i.m. and ceftiofur i.m. (n=33). Sixty-nine, 22, and 9% of initial cultures were gram-negative, gram-positive, and mixed, respectively. Logistic regression analysis showed no significant associations between treatment groups and loss of quarter, recurrence, or culling. Mixed infections, positive milk culture at 7 d after leaving hospital pen, decreased rumen motility, and absence of udder firmness were associated with increased odds of mastitis recurrence. The results suggest that i.m. ceftiofur treatment has no beneficial effects on the outcome of systemically mild clinical mastitis.
Bibliography:http://hdl.handle.net/10113/2024
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-News-1
ObjectType-Feature-3
ISSN:0022-0302
1525-3198
DOI:10.3168/jds.S0022-0302(05)73034-4